Stockreport

Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results [Yahoo! Finance]

Inventiva S.A. - American Depository Shares  (IVA) 
PDF company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), also known as non-alcoh [Read more]